Press Coverage

From Trading Floors to Cellular Therapy: Diederik van der Reijt's Vision

Former trader turned biotech entrepreneur Diederik van der Reijt leads breakthrough developments in cellular rejuvenation technology at Celljevity.

HealthTech Zone

External Publication

Read Original Article
From Trading Floors to Cellular Therapy: Diederik van der Reijt's Vision

From Trading Floors to Cellular Therapy: Diederik van der Reijt's Vision

This profile piece from HealthTech Zone explores our CEO's journey from finance to biotech and his vision for making longevity medicine accessible.

The article highlights how former trader turned biotech entrepreneur Diederik van der Reijt leads breakthrough developments in cellular rejuvenation technology at Celljevity.

Read the full article on HealthTech Zone

Medical Disclaimer: Celljevity's Prometheus technology is currently investigational and not approved by the FDA. Treatment availability varies by jurisdiction. Individual results may vary. Please consult with your healthcare provider. The statements on this website have not been evaluated by the Food and Drug Administration. Our treatments are not intended to diagnose, treat, cure, or prevent any disease.